Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

The American federal government ends shutdown, but the restart time may be over a week.

U.S. Energy Corp. received a key approval from the Department of Energy, and investment bank Wade Bush reiterated its "outperform" rating on Oklo (OKLO.US), stating that it outperformed the market.

HK Stock Market Move | BABA-W(09988) rose more than 3% in the afternoon, reports say Alibaba has secretly launched the "Thousand Questions" project to fully benchmark ChatGPT.
The American federal government ends shutdown, but the restart time may be over a week.

U.S. Energy Corp. received a key approval from the Department of Energy, and investment bank Wade Bush reiterated its "outperform" rating on Oklo (OKLO.US), stating that it outperformed the market.

HK Stock Market Move | BABA-W(09988) rose more than 3% in the afternoon, reports say Alibaba has secretly launched the "Thousand Questions" project to fully benchmark ChatGPT.

RECOMMEND

Younger consumers are dining out less at Chipotle and Cava while still buying Coach handbags
10/11/2025

Target’s deteriorating in-store experience risks recovery — retailer bets on a refined fulfillment model to fix it
10/11/2025

China suspends approval ban on exports of certain metals used in chip and electronics manufacturing to the U.S.
10/11/2025


